SFRP5 and metabolic dysfunction-associated steatohepatitis: For example, mice deficient in Sfrp1 exhibit increased adiposity and hepatic steatosis [43], and SFRP5 signaling has been shown to suppress non-alcoholic steatohepatitis [44].